Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Beta Bionics

BBNX

19.4202.51% ( -0.500 )

Closed: Sep 4, 16:00:01 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Beta Bionics (BBNX)

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and...

Open: 19.550
High: 19.970
Low: 19.000
Prev. Close: 19.920
Volume: 1.41M
Turnover: 27.28M
Avg Price: 19.385
Bid/Ask Ratio: --
Amplitude: 4.87%
52wk High: 32.710
Volume Ratio: 1.35
Turnover Ratio: 5.32%

52wk Low: 8.800
Float Mkt Cap: 514.10M
Market Cap^USD: 873.70M
P/E^TTM: Loss
P/E^Dynamic: Loss
P/E^Static: --
EPS^TTM: -1.62
EPS^Dynamic: -2.01
EPS^Static: --
BVPS: 5.70
P/B: 3.41
Circulating Supply: 26.47M
Dividend Yield^TTM: --
Dividend^TTM: --
Shares: 44.99M
Min lot size: 1
Currency: USD

Beta Bionics Analyst Rating

Forecast & Rating

Sep 3, 2026

Price forecast

$20.314.58%

Forecast & RatingBuy

12analysts

Strong buy58.33%
Buy8.33%
Hold33.33%
Sell0.00%
Strong sell0.00%

Strong buy: 7
Buy: 1
Hold: 4
Sell: 0
Strong sell: 0

News

Simplywall · 18 hours ago
Have Beta Bionics Insiders Been Selling Stock?
MorningStar · 1 day ago, 12:57 AM
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
PUBT · 1 day ago, 09:20 PM
Beta Bionics CEO Sean Saint disposes of 5,641 common shares for $113,261.01
Market Beat · 1 day ago, 11:08 AM
Beta Bionics (NASDAQ:BBNX) Insider Sells 4,221 Shares of Stock
benzinga_article · Aug 26 at 01:36 PM
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking